{"nctId":"NCT01332188","briefTitle":"Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model","startDateStruct":{"date":"2011-04"},"conditions":["Allergic Conjunctivitis"],"count":101,"armGroups":[{"label":"AC-170 0.05%","type":"EXPERIMENTAL","interventionNames":["Drug: AC-170 0.05%"]},{"label":"AC-170 0.1%","type":"EXPERIMENTAL","interventionNames":["Drug: AC-170 0.1%"]},{"label":"AC-170 0.24%","type":"EXPERIMENTAL","interventionNames":["Drug: AC-170 0.24%"]},{"label":"AC-170 0%","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: AC-170 0%"]}],"interventions":[{"name":"AC-170 0.05%","otherNames":[]},{"name":"AC-170 0.1%","otherNames":[]},{"name":"AC-170 0.24%","otherNames":[]},{"name":"AC-170 0%","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Positive bilateral conjunctival allergen challenge (CAC) reaction\n\nExclusion Criteria:\n\n* Known contraindications or sensitivities to the study medication or its components.\n* Any ocular condition that, in the opinion of the investigator, could affect the subjects safety or trial parameters.\n* Use of disallowed medications during the period indicated prior to the study enrollment or during the study.","healthyVolunteers":false,"sex":"ALL","minimumAge":"10 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Ocular Itching at Duration of Action (16 Hours Post-dose)","description":"A treatment efficacy CAC was performed 16 hours after drop instillation. Ocular itching was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of ocular itching score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.91","spread":"0.924"},{"groupId":"OG001","value":"2.00","spread":"0.771"},{"groupId":"OG002","value":"1.65","spread":"0.963"},{"groupId":"OG003","value":"2.48","spread":"0.540"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.01","spread":"1.019"},{"groupId":"OG001","value":"2.04","spread":"0.889"},{"groupId":"OG002","value":"1.74","spread":"0.843"},{"groupId":"OG003","value":"2.55","spread":"0.550"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.86","spread":"0.907"},{"groupId":"OG001","value":"1.87","spread":"0.913"},{"groupId":"OG002","value":"1.75","spread":"0.910"},{"groupId":"OG003","value":"2.27","spread":"0.777"}]}]}]},{"type":"PRIMARY","title":"Ocular Itching at Duration of Action (24 Hours Post-dose)","description":"A treatment efficacy CAC was performed 24 hours after drop instillation. Ocular itching was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of ocular itching score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.99","spread":"0.849"},{"groupId":"OG001","value":"1.78","spread":"0.873"},{"groupId":"OG002","value":"1.90","spread":"0.804"},{"groupId":"OG003","value":"2.24","spread":"0.575"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.00","spread":"0.711"},{"groupId":"OG001","value":"1.92","spread":"0.883"},{"groupId":"OG002","value":"2.17","spread":"0.819"},{"groupId":"OG003","value":"2.24","spread":"0.686"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.77","spread":"0.774"},{"groupId":"OG001","value":"1.78","spread":"0.988"},{"groupId":"OG002","value":"1.97","spread":"0.833"},{"groupId":"OG003","value":"2.08","spread":"0.702"}]}]}]},{"type":"PRIMARY","title":"Ocular Itching at Onset of Action (15 Minutes Post-dose)","description":"A treatment efficacy CAC was performed 15 minutes after drop instillation. Ocular itching was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of ocular itching score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.05","spread":"0.804"},{"groupId":"OG001","value":"0.84","spread":"0.800"},{"groupId":"OG002","value":"0.91","spread":"0.810"},{"groupId":"OG003","value":"1.94","spread":"0.870"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.19","spread":"0.778"},{"groupId":"OG001","value":"1.09","spread":"0.941"},{"groupId":"OG002","value":"1.07","spread":"0.840"},{"groupId":"OG003","value":"2.09","spread":"0.850"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.01","spread":"0.789"},{"groupId":"OG001","value":"1.07","spread":"0.929"},{"groupId":"OG002","value":"0.97","spread":"0.843"},{"groupId":"OG003","value":"1.94","spread":"0.893"}]}]}]},{"type":"PRIMARY","title":"Conjunctival Redness at Duration of Action (16 Hours Post-dose)","description":"A treatment efficacy CAC was performed 16 hours after drop instillation. Conjunctival Redness was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of conjunctival redness score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.62","spread":"0.634"},{"groupId":"OG001","value":"1.59","spread":"0.624"},{"groupId":"OG002","value":"1.45","spread":"0.489"},{"groupId":"OG003","value":"1.79","spread":"0.359"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.68","spread":"0.606"},{"groupId":"OG001","value":"1.65","spread":"0.711"},{"groupId":"OG002","value":"1.61","spread":"0.545"},{"groupId":"OG003","value":"1.91","spread":"0.426"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.63","spread":"0.696"},{"groupId":"OG001","value":"1.58","spread":"0.721"},{"groupId":"OG002","value":"1.56","spread":"0.634"},{"groupId":"OG003","value":"1.88","spread":"0.403"}]}]}]},{"type":"PRIMARY","title":"Conjunctival Redness at Duration of Action (24 Hours Post-dose)","description":"A treatment efficacy CAC was performed 24 hours after drop instillation. Conjunctival Redness was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of conjunctival redness score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.43","spread":"0.635"},{"groupId":"OG001","value":"1.38","spread":"0.668"},{"groupId":"OG002","value":"1.71","spread":"0.628"},{"groupId":"OG003","value":"1.70","spread":"0.505"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.63","spread":"0.617"},{"groupId":"OG001","value":"1.59","spread":"0.663"},{"groupId":"OG002","value":"1.85","spread":"0.608"},{"groupId":"OG003","value":"1.90","spread":"0.489"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.61","spread":"0.617"},{"groupId":"OG001","value":"1.54","spread":"0.677"},{"groupId":"OG002","value":"1.79","spread":"0.713"},{"groupId":"OG003","value":"1.76","spread":"0.575"}]}]}]},{"type":"PRIMARY","title":"Conjunctival Redness at Onset of Action (15 Minutes Post-dose)","description":"A treatment efficacy CAC was performed 15 minutes after drop instillation. Conjunctival Redness was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of conjunctival redness score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.44","spread":"0.663"},{"groupId":"OG001","value":"1.45","spread":"0.812"},{"groupId":"OG002","value":"1.66","spread":"0.718"},{"groupId":"OG003","value":"1.88","spread":"0.541"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.81","spread":"0.670"},{"groupId":"OG001","value":"1.67","spread":"0.821"},{"groupId":"OG002","value":"1.83","spread":"0.680"},{"groupId":"OG003","value":"1.96","spread":"0.589"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.83","spread":"0.648"},{"groupId":"OG001","value":"1.67","spread":"0.868"},{"groupId":"OG002","value":"1.79","spread":"0.717"},{"groupId":"OG003","value":"1.97","spread":"0.622"}]}]}]},{"type":"SECONDARY","title":"Ciliary Redness at Duration of Action (16 Hours Post-dose)","description":"A treatment efficacy CAC was performed 16 hours after drop instillation. Ciliary Redness was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of ciliary redness score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.47","spread":"0.708"},{"groupId":"OG001","value":"1.53","spread":"0.758"},{"groupId":"OG002","value":"1.34","spread":"0.684"},{"groupId":"OG003","value":"1.81","spread":"0.527"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.60","spread":"0.707"},{"groupId":"OG001","value":"1.65","spread":"0.842"},{"groupId":"OG002","value":"1.52","spread":"0.732"},{"groupId":"OG003","value":"1.99","spread":"0.523"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.60","spread":"0.703"},{"groupId":"OG001","value":"1.65","spread":"0.878"},{"groupId":"OG002","value":"1.53","spread":"0.788"},{"groupId":"OG003","value":"1.95","spread":"0.573"}]}]}]},{"type":"SECONDARY","title":"Ciliary Redness at Duration of Action (24 Hours Post-dose)","description":"A treatment efficacy CAC was performed 24 hours after drop instillation. Ciliary Redness was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of ciliary redness score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.36","spread":"0.730"},{"groupId":"OG001","value":"1.22","spread":"0.686"},{"groupId":"OG002","value":"1.50","spread":"0.633"},{"groupId":"OG003","value":"1.55","spread":"0.582"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.49","spread":"0.596"},{"groupId":"OG001","value":"1.47","spread":"0.723"},{"groupId":"OG002","value":"1.74","spread":"0.716"},{"groupId":"OG003","value":"1.77","spread":"0.544"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.50","spread":"0.617"},{"groupId":"OG001","value":"1.47","spread":"0.701"},{"groupId":"OG002","value":"1.65","spread":"0.736"},{"groupId":"OG003","value":"1.65","spread":"0.599"}]}]}]},{"type":"SECONDARY","title":"Ciliary Redness at Onset of Action (15 Minutes Post-dose)","description":"A treatment efficacy CAC was performed 15 minutes after drop instillation. Ciliary Redness was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of ciliary redness score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.24","spread":"0.689"},{"groupId":"OG001","value":"1.24","spread":"0.867"},{"groupId":"OG002","value":"1.27","spread":"0.858"},{"groupId":"OG003","value":"1.67","spread":"0.628"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.59","spread":"0.749"},{"groupId":"OG001","value":"1.51","spread":"0.861"},{"groupId":"OG002","value":"1.64","spread":"0.669"},{"groupId":"OG003","value":"1.77","spread":"0.661"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.65","spread":"0.647"},{"groupId":"OG001","value":"1.52","spread":"0.952"},{"groupId":"OG002","value":"1.73","spread":"0.622"},{"groupId":"OG003","value":"1.79","spread":"0.644"}]}]}]},{"type":"SECONDARY","title":"Episcleral Redness at Duration of Action (16 Hours Post-dose)","description":"A treatment efficacy CAC was performed 16 hours after drop instillation. Episcleral Redness was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of episcleral redness score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.68","spread":"0.602"},{"groupId":"OG001","value":"1.74","spread":"0.690"},{"groupId":"OG002","value":"1.57","spread":"0.497"},{"groupId":"OG003","value":"1.90","spread":"0.439"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.81","spread":"0.639"},{"groupId":"OG001","value":"1.77","spread":"0.757"},{"groupId":"OG002","value":"1.69","spread":"0.605"},{"groupId":"OG003","value":"2.02","spread":"0.484"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.80","spread":"0.629"},{"groupId":"OG001","value":"1.73","spread":"0.797"},{"groupId":"OG002","value":"1.69","spread":"0.647"},{"groupId":"OG003","value":"1.97","spread":"0.458"}]}]}]},{"type":"SECONDARY","title":"Episcleral Redness at Duration of Action (24 Hours Post-dose)","description":"A treatment efficacy CAC was performed 24 hours after drop instillation. Episcleral Redness was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of episcleral redness score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.53","spread":"0.590"},{"groupId":"OG001","value":"1.37","spread":"0.681"},{"groupId":"OG002","value":"1.73","spread":"0.616"},{"groupId":"OG003","value":"1.80","spread":"0.505"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.72","spread":"0.585"},{"groupId":"OG001","value":"1.63","spread":"0.700"},{"groupId":"OG002","value":"1.90","spread":"0.657"},{"groupId":"OG003","value":"2.00","spread":"0.505"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.70","spread":"0.579"},{"groupId":"OG001","value":"1.60","spread":"0.688"},{"groupId":"OG002","value":"1.87","spread":"0.696"},{"groupId":"OG003","value":"1.85","spread":"0.530"}]}]}]},{"type":"SECONDARY","title":"Episcleral Redness at Onset of Action (15 Minutes Post-dose)","description":"A treatment efficacy CAC was performed 15 minutes after drop instillation. Episcleral Redness was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of episcleral redness score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.52","spread":"0.644"},{"groupId":"OG001","value":"1.49","spread":"0.782"},{"groupId":"OG002","value":"1.64","spread":"0.744"},{"groupId":"OG003","value":"1.93","spread":"0.508"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.86","spread":"0.652"},{"groupId":"OG001","value":"1.73","spread":"0.803"},{"groupId":"OG002","value":"1.98","spread":"0.698"},{"groupId":"OG003","value":"2.01","spread":"0.575"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.91","spread":"0.577"},{"groupId":"OG001","value":"1.72","spread":"0.861"},{"groupId":"OG002","value":"1.88","spread":"0.644"},{"groupId":"OG003","value":"2.04","spread":"0.598"}]}]}]},{"type":"SECONDARY","title":"Chemosis at Duration of Action (16 Hours Post-dose)","description":"A treatment efficacy CAC was performed 16 hours after drop instillation. Chemosis was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of chemosis score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.71","spread":"0.553"},{"groupId":"OG001","value":"0.58","spread":"0.406"},{"groupId":"OG002","value":"0.53","spread":"0.292"},{"groupId":"OG003","value":"0.72","spread":"0.532"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.93","spread":"0.557"},{"groupId":"OG001","value":"0.70","spread":"0.545"},{"groupId":"OG002","value":"0.60","spread":"0.354"},{"groupId":"OG003","value":"0.99","spread":"0.575"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.92","spread":"0.644"},{"groupId":"OG001","value":"0.72","spread":"0.583"},{"groupId":"OG002","value":"0.71","spread":"0.460"},{"groupId":"OG003","value":"1.00","spread":"0.650"}]}]}]},{"type":"SECONDARY","title":"Chemosis at Duration of Action (24 Hours Post-dose)","description":"A treatment efficacy CAC was performed 24 hours after drop instillation. Chemosis was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of chemosis score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.68","spread":"0.478"},{"groupId":"OG001","value":"0.52","spread":"0.279"},{"groupId":"OG002","value":"0.55","spread":"0.298"},{"groupId":"OG003","value":"0.68","spread":"0.399"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.87","spread":"0.612"},{"groupId":"OG001","value":"0.64","spread":"0.396"},{"groupId":"OG002","value":"0.77","spread":"0.433"},{"groupId":"OG003","value":"0.81","spread":"0.532"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.90","spread":"0.647"},{"groupId":"OG001","value":"0.71","spread":"0.419"},{"groupId":"OG002","value":"0.84","spread":"0.572"},{"groupId":"OG003","value":"0.90","spread":"0.568"}]}]}]},{"type":"SECONDARY","title":"Chemosis at Onset of Action (15 Minutes Post-dose)","description":"A treatment efficacy CAC was performed 15 minutes after drop instillation. Chemosis was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of chemosis score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.49","spread":"0.232"},{"groupId":"OG001","value":"0.43","spread":"0.293"},{"groupId":"OG002","value":"0.54","spread":"0.277"},{"groupId":"OG003","value":"0.74","spread":"0.427"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.74","spread":"0.423"},{"groupId":"OG001","value":"0.52","spread":"0.314"},{"groupId":"OG002","value":"0.79","spread":"0.456"},{"groupId":"OG003","value":"0.80","spread":"0.554"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.71","spread":"0.403"},{"groupId":"OG001","value":"0.53","spread":"0.363"},{"groupId":"OG002","value":"0.76","spread":"0.399"},{"groupId":"OG003","value":"0.88","spread":"0.555"}]}]}]},{"type":"SECONDARY","title":"Eyelid Swelling at Duration of Action (16 Hours Post-dose)","description":"A treatment efficacy CAC was performed 16 hours after drop instillation. Eyelid swelling was assessed by the patient on a 0-3 scale (0=none to 3=severe). Average of eyelid swelling score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"0.75"},{"groupId":"OG001","value":"0.8","spread":"0.66"},{"groupId":"OG002","value":"0.8","spread":"0.66"},{"groupId":"OG003","value":"0.9","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"0.79"},{"groupId":"OG001","value":"0.9","spread":"0.75"},{"groupId":"OG002","value":"0.8","spread":"0.54"},{"groupId":"OG003","value":"1.1","spread":"0.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"0.76"},{"groupId":"OG001","value":"0.8","spread":"0.73"},{"groupId":"OG002","value":"0.7","spread":"0.56"},{"groupId":"OG003","value":"1.0","spread":"0.85"}]}]}]},{"type":"SECONDARY","title":"Eyelid Swelling at Duration of Action (24 Hours Post-dose)","description":"A treatment efficacy CAC was performed 24 hours after drop instillation. Eyelid swelling was assessed by the patient on a 0-3 scale (0=none to 3=severe). Average of eyelid swelling score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"0.60"},{"groupId":"OG001","value":"0.7","spread":"0.54"},{"groupId":"OG002","value":"0.9","spread":"0.68"},{"groupId":"OG003","value":"0.7","spread":"0.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"0.70"},{"groupId":"OG001","value":"0.8","spread":"0.73"},{"groupId":"OG002","value":"0.9","spread":"0.82"},{"groupId":"OG003","value":"0.9","spread":"0.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"0.69"},{"groupId":"OG001","value":"0.8","spread":"0.76"},{"groupId":"OG002","value":"0.9","spread":"0.72"},{"groupId":"OG003","value":"0.9","spread":"0.85"}]}]}]},{"type":"SECONDARY","title":"Eyelid Swelling at Onset of Action (15 Minutes Post-dose)","description":"A treatment efficacy CAC was performed 15 minutes after drop instillation. Eyelid swelling was assessed by the patient on a 0-3 scale (0=none to 3=severe). Average of eyelid swelling score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"0.56"},{"groupId":"OG001","value":"0.5","spread":"0.70"},{"groupId":"OG002","value":"0.5","spread":"0.49"},{"groupId":"OG003","value":"0.7","spread":"0.81"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"0.68"},{"groupId":"OG001","value":"0.6","spread":"0.65"},{"groupId":"OG002","value":"0.6","spread":"0.65"},{"groupId":"OG003","value":"0.8","spread":"0.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"0.71"},{"groupId":"OG001","value":"0.6","spread":"0.58"},{"groupId":"OG002","value":"0.5","spread":"0.49"},{"groupId":"OG003","value":"0.7","spread":"0.84"}]}]}]},{"type":"SECONDARY","title":"Tearing at Duration of Action (16 Hours Post-dose)","description":"A treatment efficacy CAC was performed 16 hours after drop instillation. Tearing was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of tearing score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"1.07"},{"groupId":"OG001","value":"0.8","spread":"0.72"},{"groupId":"OG002","value":"0.6","spread":"0.51"},{"groupId":"OG003","value":"0.6","spread":"0.67"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"0.89"},{"groupId":"OG001","value":"0.5","spread":"0.64"},{"groupId":"OG002","value":"0.7","spread":"0.65"},{"groupId":"OG003","value":"0.9","spread":"0.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"0.85"},{"groupId":"OG001","value":"0.4","spread":"0.63"},{"groupId":"OG002","value":"0.7","spread":"0.62"},{"groupId":"OG003","value":"0.9","spread":"0.97"}]}]}]},{"type":"SECONDARY","title":"Tearing at Duration of Action (24 Hours Post-dose)","description":"A treatment efficacy CAC was performed 24 hours after drop instillation. Tearing was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of tearing score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"0.78"},{"groupId":"OG001","value":"0.7","spread":"0.61"},{"groupId":"OG002","value":"0.6","spread":"0.75"},{"groupId":"OG003","value":"0.8","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"0.79"},{"groupId":"OG001","value":"0.6","spread":"0.54"},{"groupId":"OG002","value":"0.7","spread":"0.66"},{"groupId":"OG003","value":"0.8","spread":"0.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":"0.77"},{"groupId":"OG001","value":"0.5","spread":"0.53"},{"groupId":"OG002","value":"0.7","spread":"0.72"},{"groupId":"OG003","value":"0.7","spread":"0.84"}]}]}]},{"type":"SECONDARY","title":"Tearing at Onset of Action (15 Minutes Post-dose)","description":"A treatment efficacy CAC was performed 15 minutes after drop instillation. Tearing was assessed by the patient on a 0-4 scale (0=none to 4=severe). Average of tearing score over both eyes was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"0.74"},{"groupId":"OG001","value":"0.5","spread":"0.49"},{"groupId":"OG002","value":"0.3","spread":"0.56"},{"groupId":"OG003","value":"0.6","spread":"0.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"0.66"},{"groupId":"OG001","value":"0.5","spread":"0.50"},{"groupId":"OG002","value":"0.4","spread":"0.50"},{"groupId":"OG003","value":"0.6","spread":"0.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"0.60"},{"groupId":"OG001","value":"0.4","spread":"0.47"},{"groupId":"OG002","value":"0.2","spread":"0.33"},{"groupId":"OG003","value":"0.6","spread":"0.90"}]}]}]},{"type":"SECONDARY","title":"Rhinorrhea at Duration of Action (16 Hours Post-dose)","description":"A treatment efficacy CAC was performed 16 hours after drop instillation. Rhinorrhea was assessed by the patient on a 0-4 scale (0=none to 4=severe). Rhinorrhea score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"1.26"},{"groupId":"OG001","value":"0.4","spread":"0.49"},{"groupId":"OG002","value":"0.7","spread":"0.99"},{"groupId":"OG003","value":"0.7","spread":"0.80"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"1.01"},{"groupId":"OG001","value":"0.6","spread":"0.77"},{"groupId":"OG002","value":"1.1","spread":"1.04"},{"groupId":"OG003","value":"1.0","spread":"1.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":"1.14"},{"groupId":"OG001","value":"0.7","spread":"0.80"},{"groupId":"OG002","value":"1.1","spread":"1.05"},{"groupId":"OG003","value":"1.1","spread":"1.24"}]}]}]},{"type":"SECONDARY","title":"Rhinorrhea at Duration of Action (24 Hours Post-dose)","description":"A treatment efficacy CAC was performed 24 hours after drop instillation. Rhinorrhea was assessed by the patient on a 0-4 scale (0=none to 4=severe). Rhinorrhea score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"1.28"},{"groupId":"OG001","value":"0.6","spread":"0.65"},{"groupId":"OG002","value":"0.8","spread":"0.90"},{"groupId":"OG003","value":"0.7","spread":"0.69"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"1.29"},{"groupId":"OG001","value":"0.7","spread":"0.69"},{"groupId":"OG002","value":"1.2","spread":"0.91"},{"groupId":"OG003","value":"1.0","spread":"0.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"1.28"},{"groupId":"OG001","value":"0.6","spread":"0.70"},{"groupId":"OG002","value":"1.0","spread":"0.71"},{"groupId":"OG003","value":"0.8","spread":"0.90"}]}]}]},{"type":"SECONDARY","title":"Rhinorrhea at Onset of Action (15 Minutes Post-dose)","description":"A treatment efficacy CAC was performed 15 minutes after drop instillation. Rhinorrhea was assessed by the patient on a 0-4 scale (0=none to 4=severe). Rhinorrhea score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"1.20"},{"groupId":"OG001","value":"0.2","spread":"0.41"},{"groupId":"OG002","value":"0.3","spread":"0.58"},{"groupId":"OG003","value":"0.6","spread":"0.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"1.25"},{"groupId":"OG001","value":"0.4","spread":"0.65"},{"groupId":"OG002","value":"0.5","spread":"0.75"},{"groupId":"OG003","value":"0.8","spread":"0.87"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"1.23"},{"groupId":"OG001","value":"0.4","spread":"0.71"},{"groupId":"OG002","value":"0.5","spread":"0.68"},{"groupId":"OG003","value":"0.6","spread":"0.70"}]}]}]},{"type":"SECONDARY","title":"Nasal Pruritus at Duration of Action (16 Hours Post-dose)","description":"A treatment efficacy CAC was performed 16 hours after drop instillation. Nasal Pruritus was assessed by the patient on a 0-4 scale (0=none to 4=severe). Nasal Pruritus score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"0.91"},{"groupId":"OG001","value":"0.2","spread":"0.37"},{"groupId":"OG002","value":"0.5","spread":"0.65"},{"groupId":"OG003","value":"0.4","spread":"0.71"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"0.91"},{"groupId":"OG001","value":"0.4","spread":"0.65"},{"groupId":"OG002","value":"0.7","spread":"0.80"},{"groupId":"OG003","value":"0.8","spread":"1.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"0.99"},{"groupId":"OG001","value":"0.6","spread":"0.91"},{"groupId":"OG002","value":"0.6","spread":"0.65"},{"groupId":"OG003","value":"0.8","spread":"1.13"}]}]}]},{"type":"SECONDARY","title":"Nasal Pruritus at Duration of Action (24 Hours Post-dose)","description":"A treatment efficacy CAC was performed 24 hours after drop instillation. Nasal Pruritus was assessed by the patient on a 0-4 scale (0=none to 4=severe). Nasal Pruritus score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"0.93"},{"groupId":"OG001","value":"0.4","spread":"0.64"},{"groupId":"OG002","value":"0.4","spread":"0.58"},{"groupId":"OG003","value":"0.4","spread":"0.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"1.03"},{"groupId":"OG001","value":"0.4","spread":"0.58"},{"groupId":"OG002","value":"0.8","spread":"0.93"},{"groupId":"OG003","value":"0.6","spread":"0.99"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"0.90"},{"groupId":"OG001","value":"0.5","spread":"0.65"},{"groupId":"OG002","value":"0.6","spread":"0.82"},{"groupId":"OG003","value":"0.7","spread":"0.85"}]}]}]},{"type":"SECONDARY","title":"Nasal Pruritus at Onset of Action (15 Minutes Post-dose)","description":"A treatment efficacy CAC was performed 15 minutes after drop instillation. Nasal Pruritus was assessed by the patient on a 0-4 scale (0=none to 4=severe). Nasal Pruritus score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"0.99"},{"groupId":"OG001","value":"0.2","spread":"0.37"},{"groupId":"OG002","value":"0.3","spread":"0.56"},{"groupId":"OG003","value":"0.4","spread":"0.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"0.84"},{"groupId":"OG001","value":"0.3","spread":"0.56"},{"groupId":"OG002","value":"0.2","spread":"0.44"},{"groupId":"OG003","value":"0.4","spread":"0.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"0.95"},{"groupId":"OG001","value":"0.4","spread":"0.64"},{"groupId":"OG002","value":"0.3","spread":"0.66"},{"groupId":"OG003","value":"0.4","spread":"0.65"}]}]}]},{"type":"SECONDARY","title":"Ear or Palate Pruritus at Duration of Action (16 Hours Post-dose)","description":"A treatment efficacy CAC was performed 16 hours after drop instillation. Ear or Palate Pruritus was assessed by the patient on a single 0-4 scale (0=none to 4=severe). Ear or Palate Pruritus score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.4","spread":"0.87"},{"groupId":"OG001","value":"0.4","spread":"0.57"},{"groupId":"OG002","value":"0.3","spread":"0.74"},{"groupId":"OG003","value":"0.5","spread":"0.87"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"1.09"},{"groupId":"OG001","value":"0.8","spread":"0.90"},{"groupId":"OG002","value":"0.5","spread":"0.77"},{"groupId":"OG003","value":"1.0","spread":"1.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"1.11"},{"groupId":"OG001","value":"0.9","spread":"0.91"},{"groupId":"OG002","value":"0.8","spread":"0.93"},{"groupId":"OG003","value":"1.2","spread":"1.31"}]}]}]},{"type":"SECONDARY","title":"Ear or Palate Pruritus at Duration of Action (24 Hours Post-dose)","description":"A treatment efficacy CAC was performed 24 hours after drop instillation. Ear or Palate Pruritus was assessed by the patient on a single 0-4 scale (0=none to 4=severe). Ear or Palate Pruritus score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"0.89"},{"groupId":"OG001","value":"0.3","spread":"0.46"},{"groupId":"OG002","value":"0.4","spread":"0.76"},{"groupId":"OG003","value":"0.5","spread":"0.96"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"0.96"},{"groupId":"OG001","value":"0.6","spread":"0.65"},{"groupId":"OG002","value":"0.7","spread":"0.98"},{"groupId":"OG003","value":"0.8","spread":"1.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"1.11"},{"groupId":"OG001","value":"0.7","spread":"0.74"},{"groupId":"OG002","value":"0.7","spread":"0.90"},{"groupId":"OG003","value":"0.7","spread":"1.07"}]}]}]},{"type":"SECONDARY","title":"Ear or Palate Pruritus at Onset of Action (15 Minutes Post-dose)","description":"A treatment efficacy CAC was performed 15 minutes after drop instillation. Ear or Palate Pruritus was assessed by the patient on a single 0-4 scale (0=none to 4=severe). Ear or Palate Pruritus score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.6","spread":"0.99"},{"groupId":"OG001","value":"0.2","spread":"0.52"},{"groupId":"OG002","value":"0.3","spread":"0.56"},{"groupId":"OG003","value":"0.4","spread":"0.76"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"08","spread":"0.95"},{"groupId":"OG001","value":"0.4","spread":"0.76"},{"groupId":"OG002","value":"0.3","spread":"0.58"},{"groupId":"OG003","value":"0.7","spread":"1.07"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"1.01"},{"groupId":"OG001","value":"0.5","spread":"0.77"},{"groupId":"OG002","value":"0.3","spread":"0.58"},{"groupId":"OG003","value":"0.7","spread":"1.07"}]}]}]},{"type":"SECONDARY","title":"Nasal Congestion at Onset of Action (16 Hours Post-dose)","description":"A treatment efficacy CAC was performed 16 hours after drop instillation. Nasal Congestion was assessed by the patient on a 0-4 scale (0=none to 4=severe). Nasal Congestion score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"0.99"},{"groupId":"OG001","value":"0.5","spread":"0.65"},{"groupId":"OG002","value":"0.8","spread":"1.18"},{"groupId":"OG003","value":"0.8","spread":"0.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.4","spread":"1.04"},{"groupId":"OG001","value":"0.6","spread":"0.76"},{"groupId":"OG002","value":"1.0","spread":"1.19"},{"groupId":"OG003","value":"1.2","spread":"0.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5","spread":"1.05"},{"groupId":"OG001","value":"0.8","spread":"0.99"},{"groupId":"OG002","value":"1.0","spread":"1.14"},{"groupId":"OG003","value":"1.3","spread":"1.21"}]}]}]},{"type":"SECONDARY","title":"Nasal Congestion at Duration of Action (24 Hours Post-dose)","description":"A treatment efficacy CAC was performed 24 hours after drop instillation. Nasal Congestion was assessed by the patient on a 0-4 scale (0=none to 4=severe). Nasal Congestion score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"0.97"},{"groupId":"OG001","value":"0.6","spread":"0.58"},{"groupId":"OG002","value":"0.8","spread":"0.80"},{"groupId":"OG003","value":"0.7","spread":"0.69"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"0.98"},{"groupId":"OG001","value":"0.6","spread":"0.58"},{"groupId":"OG002","value":"1.2","spread":"0.94"},{"groupId":"OG003","value":"1.1","spread":"0.83"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"1.00"},{"groupId":"OG001","value":"0.6","spread":"0.65"},{"groupId":"OG002","value":"1.1","spread":"1.04"},{"groupId":"OG003","value":"1.2","spread":"0.88"}]}]}]},{"type":"SECONDARY","title":"Nasal Congestion at Onset of Action (15 Minutes Post-dose)","description":"A treatment efficacy CAC was performed 15 minutes after drop instillation. Nasal Congestion was assessed by the patient on a 0-4 scale (0=none to 4=severe). Nasal Congestion score for each time point was analyzed.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"1.05"},{"groupId":"OG001","value":"0.4","spread":"0.58"},{"groupId":"OG002","value":"0.4","spread":"0.59"},{"groupId":"OG003","value":"0.8","spread":"0.78"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"1.08"},{"groupId":"OG001","value":"0.5","spread":"0.65"},{"groupId":"OG002","value":"0.4","spread":"0.59"},{"groupId":"OG003","value":"1.4","spread":"0.86"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"1.14"},{"groupId":"OG001","value":"0.5","spread":"0.65"},{"groupId":"OG002","value":"0.4","spread":"0.59"},{"groupId":"OG003","value":"1.4","spread":"0.87"}]}]}]},{"type":"SECONDARY","title":"Nasal Composite Score at Duration of Action (16 Hours Post-dose)","description":"A nasal composite score was summed for each patient based on the presence of at least one of the following four nasal symptoms on a 0-4 scale (0=none to 4=severe): rhinorrhea; nasal pruritus; ear or palate pruritus; and nasal congestion. The percentage of subjects with at least one nasal symptom present was calculated for each time point.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"82.6","spread":null},{"groupId":"OG001","value":"66.7","spread":null},{"groupId":"OG002","value":"52.4","spread":null},{"groupId":"OG003","value":"76.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"82.6","spread":null},{"groupId":"OG001","value":"79.2","spread":null},{"groupId":"OG002","value":"90.5","spread":null},{"groupId":"OG003","value":"84.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"91.3","spread":null},{"groupId":"OG001","value":"83.3","spread":null},{"groupId":"OG002","value":"95.2","spread":null},{"groupId":"OG003","value":"84.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Nasal Composite Score at Duration of Action (24 Hours Post-dose)","description":"A nasal composite score was summed for each patient based on the presence of at least one of the following four nasal symptoms on a 0-4 scale (0=none to 4=severe): rhinorrhea; nasal pruritus; ear or palate pruritus; and nasal congestion. The percentage of subjects with at least one nasal symptom present was calculated for each time point.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"69.6","spread":null},{"groupId":"OG001","value":"76.0","spread":null},{"groupId":"OG002","value":"85.7","spread":null},{"groupId":"OG003","value":"68.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"82.6","spread":null},{"groupId":"OG001","value":"84.0","spread":null},{"groupId":"OG002","value":"90.5","spread":null},{"groupId":"OG003","value":"92.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"82.6","spread":null},{"groupId":"OG001","value":"88.0","spread":null},{"groupId":"OG002","value":"81.0","spread":null},{"groupId":"OG003","value":"92.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Nasal Composite Score at Onset of Action (15 Minutes Post-dose)","description":"A nasal composite score was summed for each patient based on the presence of at least one of the following four nasal symptoms on a 0-4 scale (0=none to 4=severe): rhinorrhea; nasal pruritus; ear or palate pruritus; and nasal congestion. The percentage of subjects with at least one nasal symptom present was calculated for each time point.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"52.2","spread":null},{"groupId":"OG001","value":"56","spread":null},{"groupId":"OG002","value":"47.6","spread":null},{"groupId":"OG003","value":"72","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"82.6","spread":null},{"groupId":"OG001","value":"56","spread":null},{"groupId":"OG002","value":"47.6","spread":null},{"groupId":"OG003","value":"84","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"73.9","spread":null},{"groupId":"OG001","value":"52","spread":null},{"groupId":"OG002","value":"52.4","spread":null},{"groupId":"OG003","value":"84","spread":null}]}]}]},{"type":"SECONDARY","title":"Tolerability of Study Medication at Visit 3A","description":"Subjects were asked to rate the comfort of the drop in each eye upon instillation, at 1 minute, and at 2 minutes after instillation of study medication. The assessment used a 10-point scale with 0 as very comfortable and 10 as very uncomfortable. Higher scores represent a worse outcome..","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"0.95"},{"groupId":"OG001","value":"0.7","spread":"1.04"},{"groupId":"OG002","value":"1.3","spread":"1.93"},{"groupId":"OG003","value":"0.6","spread":"1.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":"1.13"},{"groupId":"OG001","value":"0.9","spread":"1.13"},{"groupId":"OG002","value":"2.0","spread":"2.25"},{"groupId":"OG003","value":"0.9","spread":"1.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.8","spread":"1.10"},{"groupId":"OG001","value":"1.0","spread":"1.18"},{"groupId":"OG002","value":"1.7","spread":"2.27"},{"groupId":"OG003","value":"0.6","spread":"0.79"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":25},"commonTop":["Visual acuity reducsed","Photophobia","Petechiae","Dermatitis contact","Back pain"]}}}